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Abstract
Background: Our previous study demonstrated that a store-operated calcium channel (SOCC) inhibitor (YM-58483) has
central analgesic effects. However, the cellular and molecular mechanisms of such effects remain to be determined. It is
well-known that glial cells play important roles in central sensitization. SOC entry (SOCE) has been implicated in many
cell types including cortical astrocytes. However, the role of the SOCC family in the function of astrocytes has not
been determined. Here, we thoroughly investigated the expression and the functional significance of SOCCs in
spinal astrocytes.
Methods: Primary cultured astrocytes were prepared from neonatal (P2–P3) CD1 mice. Expressions of mRNAs and
proteins were respectively assessed by real-time PCR and Western blot analysis. SOCE was measured using a calcium
imaging system. Live-cell STIM1 translocation was detected using a confocal microscope. Cytokine levels were measured
by the enzyme-linked immunosorbent assay.
Results: We found that the SOCC family is expressed in spinal astrocytes and that depletion of calcium stores from the
endoplasmic reticulum by cyclopiazonic acid (CPA) resulted in a large sustained calcium entry, which was blocked by
SOCC inhibitors. Using the siRNA knockdown approach, we identified STIM1 and Orai1 as primary components of SOCCs
in spinal astrocytes. We also observed thapsigargin (TG)- or CPA-induced puncta formation of STIM1 and Orai1. In
addition, activation of SOCCs remarkably promoted TNF-α and IL-6 production in spinal astrocytes, which were
greatly attenuated by knockdown of STIM1 or Orai1. Importantly, knockdown of STIM2 and Orai1 dramatically
decreased lipopolysaccharide-induced TNF-α and IL-6 production without changing cell viability.
Conclusions: This study presents the first evidence that STIM1, STIM2, and Orai1 mediate SOCE and are involved
in cytokine production in spinal astrocytes. Our findings provide the basis for future assessment of SOCCs in pain
and other central nervous system disorders associated with abnormal astrocyte activities.
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Background
Glial cells have long been viewed as static constituents
of the CNS, primarily serving support functions. This
view was dramatically changed when Garrison et al.
found that spinal cord astrocytes were activated following
nerve injury in 1991 [1]. Accumulating evidence impli-
cates that spinal cord glia are key players in the develop-
ment and maintenance of pathological pain [2, 3]. There
are three major groups of glial cells: astrocytes, microglia,
and oligodendrocytes. Astrocytes represent the largest glial
cell population in the CNS. Compared with microglia and
oligodendrocytes, astrocytes are more closely associated
with neurons and blood vessels. One single astrocyte can
enwrap four to eight neuronal somata and make a connec-
tion with 300–600 neuronal dendrites [4], which allow as-
trocytes to regulate the external chemical environment of
neurons during synaptic transmission. Increasing evidence
indicates that microglia play a role in the development of
chronic pain conditions, while astrocytes are more import-
ant for the maintenance of chronic pain [5]. Notably,
several studies showed that bone cancer pain, oxaliplatin-
and bortezomib-induced peripheral neuropathy, and
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collagen-induced arthritis pain models showed marked
spinal astrocyte activation with limited microglial activa-
tion [6–8]. Although targeting astrocytes is beneficial in
treating chronic pain, the inhibition of astrocytes may also
attenuate normal astrocyte functions, such as glutamate
uptake. Therefore, therapeutic strategies should be di-
rected at more specific astrocyte functions or at specific
aspects of reactive astrogliosis, by targeting astrocyte-
related molecular mechanisms. However, the molecular
mechanisms that regulate specific aspects of reactive
astrogliosis such as cytokine production remain elusive.
Store-operated calcium channels (SOCCs) are highly
Ca2+-selective cation channels that can be activated by
depletion of endoplasmic reticulum (ER) calcium stores,
as first postulated in 1986 [9]. SOCCs are composed of
ER calcium sensors STIM1/2 and pore-forming proteins
Orai1/2/3 in most cell types. SOC entry (SOCE) is a major
mechanism for triggering Ca2+ influx in immune cells.
Additionally, SOCE is involved in cytokine production in
immune cells [10–12]. Previous studies have demonstrated
that YM-58483, a potent inhibitor of SOCCs, blocks
SOCCs in immune cells and reduces cytokine production
from these cells [13–15]. Our previous study showed that
systemic administration of YM-58483 produces strong
analgesic and anti-inflammatory actions with peripheral
mechanisms associated with reduction of pro-inflammatory
cytokines [16, 17]. Interestingly, intrathecal injection of
YM-58483 also attenuates pain hypersensitivity [17]. How-
ever, the mechanisms underlying its central action remain
to be determined. It has also been shown that STIM1 and
Orai1 mediate SOCE in cortical astrocytes [18]. It is there-
fore reasonable to hypothesize that SOCE is an important
Ca2+ signal in spinal astrocytes. In the present study, we
demonstrate that SOCCs are expressed in mouse spinal
cord astrocytes. We also identified STIM1, STIM2, and
Orai1 as the players of SOCE. Importantly, SOCE can in-
duce TNF-α and IL-6 production, and STIM2 and Orai1
play an important role in lipopolysaccharide (LPS)-induced
cytokine production from spinal astrocytes. These findings
reveal that SOCE is an important component of Ca2+
signaling in spinal astrocytes and regulates cytokine pro-




All experiments were done in accordance with the
guidelines of the National Institutes of Health and the
Committee for Research and Ethical Issues of IASP
and were approved by the Drexel University Animal
Care and Use Committee. Pregnant CD1 mice were
purchased from Charles River (Wilmington, MA) and
individually housed in standard cages in 12-h light/
dark cycle.
Cell culture
Primary cultures of spinal cord astrocytes were prepared
from neonatal (P2–P3) mice. Briefly, neonatal mice were
decapitated after inducing hypothermia on ice. A lamin-
ectomy was performed and the spinal cord was carefully
removed. The meninges were removed, and spinal cord
strips were then incubated for 30 min at 37 °C in Hank’s
balanced salt solution (HBSS) (Invitrogen, Carlsbad, CA)
(in mM: 137 NaCl, 5.4 KCl, 0.4 KH2PO4, 1 CaCl2, 0.5
MgCl2, 0.4 MgSO4, 4.2 NaHCO3, 0.3 Na2HPO4, and
5.6 glucose) containing papain (15 U/ml; Worthington
Biochemical, Lakewood, NJ), rinsed three times with
HBSS, and placed in minimum essential media (MEM)
(Invitrogen) containing 10 % fetal calf serum (FCS,
Invitrogen). The strips were mechanically dissociated
by gently triturating with a pipette. The resulting cells
were plated in 75 cm2 flask. Cells were maintained at
37 °C in a humidified atmosphere containing 5 % CO2.
Culture medium was changed to Dulbecco’s modified
Eagle’s medium (DMEM, Invitrogen) containing 10 %
FCS after 24 h and then allowed to grow for 6–8 days
until 70 % confluent. Cells were shaken in an orbital
shaker (320 rpm) for 2 to 3 h to detach cells sitting on
top of the astrocyte monolayer (mainly microglia and
precursor cells) [19, 20] and then were trypsinized and
re-plated to six-well plates for Western blotting ana-
lysis, 96-well plates for enzyme-linked immunosorbent
assay, or 12-mm coverslips for calcium imaging in
MEM culture media.
Real-time PCR analysis of mRNA expression
Real-time PCR was performed according to our previous
study [21]. Total RNA was extracted from astrocytes
using TRIzol Reagent (Molecular Research Center, Inc.,
Cincinnati, OH). The RNA concentration was deter-
mined by optical density at 260 nm. Total RNA was
reverse transcribed into cDNA for each sample using a
Fermentas cDNA synthesis kit (Thermo Scientific,
Rockford, IL) following the manufacturer’s instructions.
Specific primers for mouse STIM1 (Mm00486423_m1),
STIM2 (Mm01223103_m1), Orai1 (Mm00774349_m1),
Orai2 (Mm04214089_s1), Orai3 (Mm01612888_m1), and
GAPDH were purchased from Applied Biosystems (Foster
City, CA). Real-time quantitative PCR was performed in a
7900HT fast real-time PCR System (Applied Biosystems)
using the following amplification conditions: 5 min of ini-
tial denaturation at 96 °C, then 35 cycles of 96 °C for 30 s,
55 °C for 30 s, and 72 °C for 1.5 min. The threshold cycle
for each gene was determined and analyzed using the rela-
tive quantitation software (Applied Biosystems). The rela-
tive expression of the target genes was calculated using
the 2(−Delta Delta CT, 2
−ΔΔCT) method. The mRNA levels
of STIM1, STIM2, Orai1, Orai2, and Orai3 were normal-
ized to the housekeeping gene GAPDH.
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Western blot analysis
Astrocytes were washed in PBS and lysed in an ice-cold
radio immunoprecipitation assay (RIPA) buffer containing
50 mM Tris HCl, 150 mM NaCl, 0.2 mM EDTA, 1 % Tri-
ton X-100, 2 % sodium dodecyl sulfate, 1 % deoxycholate,
0.1 mM phenylmethanesulfonyl fluoride, and protease
inhibitor cocktails (Thermo Fisher Scientific). The lysed
astrocytes were then sonicated at a constant intensity of
2.5 for 10 s, and centrifuged at 12,000 RPM (4 °C) for
5 min. The concentration of total protein was deter-
mined using a Pierce bicinchoninic acid protein assay
kit (Thermo Fisher Scientific) following the manufac-
turer’s instructions. Protein samples were heated at
95 °C for 5 min, electrophoresed in 10 % sodium do-
decyl sulfate polyacrylamide gel, and transferred onto
polyvinylidene fluoride membranes (Millipore, Billerica,
MA). The blots were blocked with 5 % skimmed milk in
Tris-buffered saline–Tween 0.1 % for 1 h at room
temperature and probed with rabbit anti-STIM1 (1:8000,
Cell Signaling, Danvers, MA), anti-STIM2 (1:8000, ProSci,
Inc., Poway, CA), anti-Orai1 (1:500, ProSci), anti-Orai2
(1:500, ProSci), anti-Orai3 (1:500, ProSci), and anti-
GAPDH (1:10,000, Cell Signaling) primary antibodies at
4 °C overnight. The blots were washed and incubated
for 1 h at room temperature with the horseradish per-
oxidase–conjugated secondary antibody (1:10,000, Cell
Signaling) and then developed with enhanced chemilu-
minescence (Millipore). The densitometry of protein
bands was quantified using Image J software (NIH).
Calcium imaging
Calcium imaging was performed using fura-2-based micro-
fluorimetry and imaging analysis as we previously described
[21]. Astrocytes were loaded with 4 μM of fura-2AM (Life
Technologies, Grand Island, NY) for 30 min at room
temperature in HBSS, washed, and further incubated in
normal bath solution (Tyrode’s) containing (in mM) 140
NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 5.6 glucose
for 20 min. Coverslips were mounted in a small laminar-
flow perfusion chamber (Model RC-25, Warner Instru-
ments, Hamden, CT) and continuously perfused at 5 to
7 ml/min with Tyrode’s solution. Images were acquired at
3-s intervals at room temperature (20–22 °C) using an
Olympus inverted microscope equipped with a CCD cam-
era (Hamamatsu ORCA-03G, Japan). The fluorescence
images were recorded and analyzed using the software
MetaFluor 7.7.9 (Molecular Devices). The fluorescence ra-
tio was determined as the fluorescence intensities excited at
340 and 380 nm with background subtraction. Only one re-
cording was made from each coverslip.
Transfection
For transfection of siRNAs, astrocytes were cultured on
glass coverslips (for calcium imaging) and plates (for
PCR and Western blot analysis) for 24 h and then trans-
fected with STIM1 siRNA (Dharmacon, Lafayette, CO,
USA), STIM2 siRNA, or Scramble siRNA (Dharmacon,
Lafayette, CO) using X-tremeGENE HP Transfection
Reagent (Roche Applied Science, Indianapolis, USA)
following the manufacturer’s instructions as described in
our previous study [21]. For transfection of Orai siRNAs,
astrocytes were electroporated using a mouse Nucleofec-
tor kit according to the manufacturer’s instructions (Lonza
Group Ltd, Basel, Switzerland) as described in our previ-
ous study [21]. Briefly, astrocytes were transfected with
12 μg of Orai1 siRNA (Life Technologies, Grand Island,
NY), Orai2 siRNA (Dharmacon), Orai3 siRNA (Dharma-
con), or Scramble siRNA (Life Technologies for Orai1;
Dharmacon for Orai2 and Orai3) per 1 × 106 cells. Cal-
cium imaging and Western blot analysis were performed
48–72 h post transfection. For transfection of STIM1-YFP
and Orai1-CFP (generous gifts from Dr. Gill, Temple Uni-
versity, PA), astrocytes were electroporated using mouse
primary cell Nucleofector kit according to the manufac-
turer’s instructions (Lonza Group Ltd, Basel, Switzerland).
Briefly, astrocytes were transfected with 1.5 μg STIM1-
YFP alone or co-transfected with Orai1-CFP (2.5 μg) per
1 × 106 cells and were seeded on 15-mm glass coverslips.
After 16 h, transfection medium was removed and astro-
cytes were fed with fresh culture medium.
Live-cell confocal imaging
All fluorescence images were captured 48–72 h post
transfection using the Olympus FLUOVIEW FV1000
confocal microscope equipped with a ×60 oil-immersion
objective. Time-lapse imaging was performed in STIM1-
YFP transfected astrocytes. Images of YFP were then ac-
quired at 20-s intervals using a 515-nm laser line for YFP
excitation, and YFP emission through a 535- to 565-nm
window. For STIM1-YFP and Orai1-CFP co-transfected
astrocytes, images of YFP and CFP were acquired at 2-
min intervals using 515- and 458-nm laser lines for excita-
tion. All experiments were performed in Tyrode’s solution
containing (mM) 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10
HEPES, and 5.6 glucose (pH 7.4) at room temperature.
The number of STIM1 puncta was quantified using
OLYMPUS FLUOVIEW Ver.3.1b. Regions of interest were
randomly selected by drawing 10 by 10 μm square boxes
in cell bodies. The same regions were used to count the
number of puncta before and after TG or CPA treatment.
The puncta were selected as spots of high fluorescence
intensity ranging from 0.4 to 2.0 μm in diameter size.
Enzyme-linked immunosorbent assay
Astrocytes were re-plated in 96-well plates (2 × 104 cells
per well). For basal cytokine level measurement, astro-
cytes were treated with 0.1 % DMSO in MEM culture
medium. For measuring cytokine production, astrocyte
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were first incubated in 0 Ca2+ Tyrode’s solution contain-
ing (in mM) 140 NaCl, 5 KCl, 1 MgCl2, 10 HEPES, and
5.6 glucose for 2 min, then treated with 1 μM TG or
30 μM CPA for 5 min. The 0 Ca2+ Tyrode’s solution was
replaced with MEM culture medium containing TG for
5 or 24 h or CPA for 24 h. For testing the effect of drugs
on TG-induced cytokine production, astrocytes were
pretreated with different concentrations of drugs for
15 min before application of TG. Astrocytes were cen-
trifuged at 1000 rpm for 5 min, and IL-6 and TNF-α
in the supernatant were measured by enzyme-linked
immunosorbent assay (ELISA) according to the manu-
facturer’s instructions (R&D Systems, Minneapolis,
MN, USA).
MTT cell viability assay
Astrocytes were cultured and re-plated in 96-well plates
(1 × 104 cells/well). Astrocytes were first incubated in 0
Ca2+ Tyrode’s solution containing (in mM) 140 NaCl, 5
KCl, 1 MgCl2, 10 HEPES, and 5.6 glucose for 2 min and
then treated with 1 μM TG for 5 min. The 0 Ca2+ Tyr-
ode’s solution was replaced with MEM culture medium
containing TG for 5 or 24 h. The cell viability was de-
termined by an assay measuring dehydrogenase activity
(Trevigen, Gaithersburg, MD) according to the manu-
facturer’s instructions. Ten microliters of MTT reagent
was added to 100 μl of MEM and incubated for 2 h at
37 °C. Once the purple precipitate was clearly visible
intracellularly under the microscope, MTT detergent
was added to dissolve the formazan crystals. The ab-
sorbance was measured directly from 96-well plates at
570 nm using a microplate reader (Spectramax Plus,
Molecular Devices, CA).
Drugs
YM-58483, KN-93, and PD98059 were purchased from
Tocris (Minneapolis, MN). Cyclopiazonic acid (CPA),
thapsigargin (TG), GdCl3, 2-aminoethyl diphenyl borate
(2-APB), and LPS were purchased from Sigma (St. Louis,
MO). They were dissolved in Milli-Q water or dimethyl
sulfoxide (DMSO) as stock solutions and further diluted
to final concentrations in 0.1 % DMSO.
Data analysis
Data are expressed as original traces or as mean ± SEM.
Treatment effects were statistically analyzed with a one-way
analysis of variance (ANOVA). When ANOVA showed a
significant difference, pairwise comparisons between means
were performed by the post hoc Bonferroni method. Paired
or two-sample Student’s t tests were used when com-
parisons were restricted to two means. Error probabil-
ities of P < 0.05 were considered statistically significant.
The statistical software Origin 8.1 was used to perform
all statistical analyses.
Results
SOCCs are expressed in spinal astrocytes
We previously demonstrated that YM-58483 possesses
a strong central analgesic effect in chronic pain condi-
tions [17], suggesting a potential role of SOCCs in
central sensitization. We have shown that SOCCs are
functional in spinal cord dorsal horn neurons [21]. To
examine whether SOCCs are also expressed in spinal
cord astrocytes, we first evaluated the purity of astro-
cytes. Cultured astrocytes were fixed and immuno-
stained with antibodies against glial fibrillary acidic
protein (GFAP) (an astroglial marker), Iba1 (a micro-
glial marker), and MAP2b (a neuronal marker). GFAP
positive cells represented 92 % of total cells (Fig. 1a),
while Iba1 positive cells were either absent or very
sparse and MAP2b positive cells were absent (data not
shown), indicating that astrocytes are the predominant
cell type in our cultured cells. To determine the
expression of SOCCs in astrocytes, we performed
Taqman RT-PCR and Western blot assays. Figure 1b
showed that all mRNAs of the SOCC family were
expressed in spinal astrocytes. Western blot results
also confirmed the expression of SOCC proteins in
spinal astrocytes (Fig. 1c). These results demonstrate
that the SOCC family is expressed in spinal astrocytes.
Fig. 1 The SOCC family is expressed in spinal astrocytes. a Immunostaining of GFAP and DAPI in cultured astrocytes. b mRNA levels of STIM1,
STIM2, Orai1, Orai2, and Orai3 in cultured astrocytes by RT-PCR (normalized to GAPDH). Values represent mean ± SEM, n = 4 samples each. c Protein
expression of STIM1, STIM2, Orai1, Orai2, and Orai3 in astrocytes by Western blot analysis. Arrows indicate the corresponding molecular weights of Orai1
and STIM2 proteins
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SOCCs are functional in spinal astrocytes
Given the expression of SOCCs in spinal astrocytes,
we then asked whether SOCCs are functional in spinal
astrocytes. We performed calcium imaging recordings
in live astrocytes. When astrocytes were pretreated
with the Ca2+-free Tyrode’s solution, 1 μM TG transi-
ently elevated intracellular Ca2+, and subsequent
addition of 2 mM CaCl2 caused calcium entry in al-
most every astrocyte (Fig. 2a). Bath-applied 3 μM YM-
58483, an inhibitor of SOCE, did not affect the cal-
cium release induced by TG but dramatically pre-
vented the calcium influx induced by TG (Fig. 2a, b).
Another inhibitor of SOCE, 2-APB, significantly reduced
both the calcium release and calcium entry of TG
(Fig. 2a, b). To test whether these inhibitors attenuate
SOCE, astrocytes were pretreated with CPA (another
Ca2+-ATPase inhibitor) to deplete calcium stores since it
produced a more sustained calcium response. Subsequent
addition of 2 mM CaCl2 induced sustained responses with
limited reductions over 10 min. GdCl3 completely blocked
CPA-induced SOCE at 1 μM concentration (Fig. 2c). YM-
58483 markedly attenuated SOCE in a concentration-
dependent manner (Fig. 2d). 2-APB slightly increased
SOCE at a low concentration and inhibited SOCE at
higher concentrations (Fig. 2e). These results indicate that
SOCCs are functional in spinal astrocytes.
Fig. 2 Depletion of endoplasmic reticulum Ca2+ stores induces SOC Entry in cultured astrocytes. a Representative calcium imaging recordings. b
Summary of effects of YM-58483 (YM, 3 μM) and 2-APB (30 μM) on TG-induced calcium influx. n = 14–22 astrocytes. c-e Effects of GdCl3 (c), YM-
58483 (d), and 2-APB (e) on CPA-induced calcium entry. Left panel, representatives; right panel, summary of effects of vehicle (control, n = 36), GdCl3 (n
= 19 cells), YM-58483 (n = 13–17 cells), and 2-APB (n = 12–22 cells) on CPA-induced calcium entry. Values represent mean ± SEM; *P < 0.05, compared
with control by the one-way ANOVA
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Orai1, STIM1, and STIM2 are responsible for SOCE in
spinal astrocytes
To identify which proteins are responsible for the SOCE
in spinal astrocytes, we knocked down each of the indi-
vidual components of the SOCC family using specific
siRNAs as demonstrated in our previous study [21].
Astrocytes transfected with the specific STIM1 siRNA at
a concentration of 1 μg/ml showed pronounced reduction
of STIM1 protein level, while it did not affect STIM2 pro-
tein level (Fig. 3a). Similarly, the specific STIM2 siRNA
drastically decreased STIM2 protein level but had no effect
on STIM1 expression (Fig. 3a). Knockdown of STIM1
greatly decreased TG-induced SOCE, while knockdown of
STIM2 significantly reduced the SOCE with less potency
(Fig. 3b). Astrocytes transfected with siRNAs targeting
Orai1, Orai2, or Orai3 showed a dramatic reduction of their
own protein levels at the corresponding bands and showed
no interference with each other (Fig. 3c). Knockdown of
Orai1 decreased SOCE by 80 %, but knockdown of Orai2
or Orai3 had no effect on SOCE in astrocytes (Fig. 3d).
These results demonstrate that STIM1 and Orai1 are pri-
mary players responsible for SOCE in spinal astrocytes.
Depletion of ER Ca2+ stores results in STIM1 translocation
Depletion of Ca2+ stores induces STIM1 puncta for-
mation in cell lines [22, 23]. To determine whether
this phenomenon also occurs in mouse spinal astro-
cytes, we transfected astrocytes with STIM1-YFP.
Transfection of STIM1-YFP resulted in expression of
STIM1 throughout the cell body except the nucleus,
and STIM1 randomly formed a few puncta in the rest-
ing state. Application of 1 μM TG induced robust
STIM1 puncta formation in a time-dependent manner
(Fig. 4a). Moreover, the average number of puncta per
100 μm2 was increased by TG or CPA treatment
(Fig. 4b). To confirm whether TG induces endogenous
STIM1 puncta formation in mouse spinal astrocytes,
we took advantage of the specific STIM1 antibody.
Cells were fixed after application of TG for 8 min.
Similar to our transfection data, vehicle treated cells
showed few randomly formed puncta, while TG treat-
ment induced obvious puncta formation in GFAP
positive cells (Fig. 4c).
Depletion of ER Ca2+ stores increases STIM1 and Orai1
puncta formation
To examine whether STIM1 forms puncta with Orai1
in astrocytes, Orai1-tagged with cyan fluorescent pro-
tein (Orai1-CFP) and STIM1-YFP were co-transfected
in astrocytes. In untreated cells, Orai1-CFP was evenly
expressed throughout the cell, except for the nucleus.
Following the addition of TG and CPA, Orai1-CFP
showed a marked change in distribution and puncta-
like formations were seen throughout the astrocytes. TG or
CPA triggered both STIM1 and Orai1 reorganization, lead-
ing to a pronounced enhancement of STIM1–Orai1 co-
localization (Fig. 5). These results suggest that STIM1
interacts with Orai1 upon Ca2+ store depletion. This
result further supports the notion that depletion of ER
Ca2+ stores causes STIM1 translocation leading to ac-
tivation of Orai1 and the subsequent calcium influx
into astrocytes.
SOCE regulates cytokine production in spinal astrocytes
Ca2+ signals in astrocytes mediate a remarkable variety
of cellular functions including cytokine production. To
determine whether SOCE plays a role in cytokine pro-
duction from spinal astrocytes, we tested effects of TG
and CPA on cytokine production. Astrocytes were pre-
treated with 1 μM TG in the Ca2+-free Tyrode’s solution
for 5 min and then replaced with MEM culture medium
containing TG for 5 or 24 h. TNF-α production was
significantly increased after a 5-h treatment compared to
control cells, and a more robust TNF-α production was
observed at the 24-h time point (Fig. 6a). Similarly, TG-
induced IL-6 production was greater after a 24-h treat-
ment (Fig. 6b). To further determine that activation of
SOCE results in cytokine production, we tested the ef-
fect of CPA on cytokine production in spinal astrocytes
using the same conditions. CPA also significantly in-
creased production of TNF-α and IL-6 after a 24-h treat-
ment (Fig. 6c). To confirm the involvement of the SOCE
in pro-inflammatory cytokine production, we investigated
the effect of SOCE inhibition on TG-induced cytokine
production. Astrocytes were pretreated with SOCC inhibi-
tors 1 μM YM-58483 and 0.3 μM GdCl3 for 15 min. Both
inhibitors significantly reduced TG-induced TNF-α and
IL-6 production (Fig. 6d). These results suggest that SOCE
plays a role in cytokine production.
TG has been implicated as a potent inductor of ER
stress and apoptotic cell death [24, 25]. To determine
whether SOCCs contribute TG- induced reduction of
cell viability, an MTT assay was performed in TG-
treated astrocytes after 5 and 24 h. At the earlier time
point, TG had no effect on cell viability despite the sig-
nificant increase in both TNF-α and IL-6 production.
Conversely, TG significantly reduced cell viability to
55 % after 24 h, while YM and GdCl3 had no effect on
TG-induced reduction of cell viability (Fig. 6d). These
data suggest that SOCCs are involved in TG- and CPA-
induced cytokine production but not in TG-induced de-
crease in cell viability. To further confirm that SOCC
proteins STIM1 and Orai1 play a role in cytokine pro-
duction, astrocytes were transfected with control siRNA
or targeting siRNAs. We found that knockdown of
STIM1 or Orai1 significantly decreased the cytokine
production but had no effect on TG-induced reduction
of cell viability (Fig. 6e). These results demonstrate that
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STIM1 and Orai1 play a role in pro-inflammatory cyto-
kine production in spinal astrocytes.
Orai1 and STIM2 are involved in LPS-induced cytokine
production
The findings described above prompted us to test whether
SOCCs are involved in cytokine production induced by
LPS, which is a well-established stimulator of cytokine
production in astrocytes. Addition of 2 ng/ml LPS largely
increased IL-6 and TNF-α after treatment for 5 h (Fig. 7a).
We then tested the effects of SOCC inhibitors 2-APB and
YM-58483 on LPS-induced IL-6 and TNF-α production,
both of which significantly reduced LPS-induced IL-6 and
TNF-α production in a concentration-dependent manner
Fig. 3 Orai1, STIM1, and STIM2 are important for SOCE in spinal astrocytes. a Effects of specific siRNAs against STIM1 or STIM2 on protein levels
of STIM1 and STIM2 (n= 4–5 samples). b Effects of specific siRNAs against STIMs on TG-induced SOCE. Left panel, representatives of TG-induced calcium
responses recorded in astrocytes transfected with control siRNA or targeting siRNAs against STIMs; right panel, summary of effects of control siRNA (n= 78),
STIM1 siRNA (n= 77), and STIM2 siRNA (n= 69). c Effects of specific siRNAs against Orai1, Orai2, or Orai3 on protein levels of Orai1, Orai2, and Orai3 (n= 4
samples each). The protein levels were normalized to control (non-target siRNA). d Effects of specific siRNAs against Orais on TG-induced SOCE. Left panel,
representatives of TG-induced calcium responses recorded in astrocytes transfected with control siRNA or targeting siRNAs against Orais; right panel,
summary of effects of control siRNA (n= 112), Orai1 siRNA (n= 76), Orai2 siRNA (n= 40), or Orai3 siRNA (n= 42). Values represent mean ± SEM, *P< 0.05,
compared with control by Student’s t test or the one-way ANOVA
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(Fig. 7a) and did not affect cell viability (data not shown).
These results suggest that SOCCs may be involved in
LPS-induced cytokine production from spinal astrocytes.
To confirm that SOCCs play a role in LPS-induced cyto-
kine production, we transfected astrocytes with the spe-
cific siRNA to knock down STIM1 in spinal astrocytes.
Interestingly, knockdown of STIM1 had no significant
effect (Fig. 7b). We then tested whether STIM2 is involved
in LPS-induced cytokine production. Indeed, reduction of
STIM2 by its specific siRNA significantly attenuated LPS-
induced IL-6 and TNF-α production, but did not signifi-
cantly affect cell viability (93 ± 7 % in the STIM2 siRNA
group vs 100 ± 5 % in the control siRNA group). Finally,
we examined whether Orai1 has an effect on cytokine pro-
duction induced by LPS, Surprisingly, decrease in Orai1
expression by its siRNA drastically reduced TNF-α pro-
duction and almost abolished IL-6 production (Fig. 7b),
while it had no effect on cell viability (104 ± 4 %) com-
pared to control siRNA. These results indicate that STIM2
and Orai1 play a critical role in LPS-induced cytokine
production.
Discussion
In the present study, we demonstrated that SOCCs are
expressed and functional in spinal astrocytes. We identi-
fied STIM1, STIM2, and Orai1 as players responsible for
Fig. 4 Depletion of calcium stores from endoplasmic reticulum induces STIM1 puncta formation in spinal astrocytes. a Live-cell confocal time-lapse images
of STIM1-transfected astrocytes treated with 1 μM thapsigargin (TG) or 30 μM cyclopiazonic acid (CPA) at 0, 4, and 8 min. b Average number of puncta per
100 μm2 induced by respective treatments. Puncta were quantified as spots of high fluorescence intensity ranging from 0.4 to 2.0 μm in
diameter size. c Confocal images of fixed spinal astrocytes containing endogenous STIM1 puncta after 8 min in the presence and absence
of TG (1 μM)
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SOCE in spinal astrocytes. Our data revealed that STIMs
and Orai1 play a role in TG- and LPS-induced cytokine
production. These findings indicate the functional import-
ance of STIM1, STIM2, and Orai1 in spinal astrocytes.
Astrocytes are the predominant cell type responsible for
the maintenance of brain homeostasis in the CNS. SOCE
is a widely recognized calcium signal in non-excitable cells
including rat brain astrocytes [26]. However, its molecular
identity remains controversial. A recent study has shown
that STIM1 and Orai1 mediate SOCE in rat cortical as-
trocytes [18]. SOCC proteins and SOCE have not been
reported in spinal cord astrocytes. In this study, we
demonstrated that the members of the SOCC family
are differentially expressed in spinal astrocytes. The cal-
cium imaging data showed that depletion of ER calcium
stores with TG or CPA-induced robust calcium entry in
astrocytes, which is inhibited by SOCC inhibitors 2-
APB, GdCl3, and YM-58483. We further identified the
Fig. 5 Depletion of calcium stores from endoplasmic reticulum induces STIM1-Orai1 puncta formation in spinal astrocytes. a Live-cell confocal images
of astrocytes transfected with STIM1-YFP and Orai1-CFP taken before and after 10 min treatment of 1 μM thapsigargin (TG) or 30 μM cyclopiazonic acid
(CPA). b Average number of STIM1 puncta (green) per 100 μm2 induced by TG or CPA. c Average number of STIM1/Orai1 puncta (yellow) per 100 μm2
induced by TG or CPA. Puncta were quantified as spots of high fluorescence intensity ranging from 0.4 to 2.0 μm in diameter size before and after
10 min TG and CPA treatments. Values represent mean ± SEM, *P < 0.05, compared with pretreatment by Student’s t test
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Fig. 6 Depletion of Ca2+ store induces cytokine production in spinal astrocytes. a TG-induced TNF-α production. b TG-induced IL-6 production. c
CPA-induced TNF-α and IL-6 production (n = 6–8). d Effects of YM-58483 (YM, 3 μM) and GdCl3 (Gd3+, 0.3 µM) on TG-induced cytokine production
and reduction of cell viability (n = 6–7). e Effects of knockdown STIM1 or Orai1 on TG-induced cytokine production and reduction of cell viability (n =
6). Values represent mean ± SEM, *P < 0.05, compared with control by Student’s t test or the one-way ANOVA
Fig. 7 LPS-induced cytokine production is inhibited by SOC inhibitors or knockdown of STIM2 or Orai1. a Effects of YM-58483 and 2-APB on
LPS-induced TNF-α and IL-6 production. b Effects of knockdown STIM1, STIM2, or Orai1 on LPS-induced TNF-α and IL-6 production. n = 6.
Values represent mean ± SEM, *P < 0.05, compared with control by the one-way ANOVA or Student’s t test
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components of SOCCs responsible for SOCE using spe-
cific siRNAs that target individual members of the SOCC
family. We found that knockdown of STIM1 dramatically
decreased TG-induced SOCE. Although STIM1 has been
shown to play a crucial role in the store-operated coupling
process, the role of STIM2 remained unclear. Some re-
ports showed that STIM2 has no effect or an inhibitory ef-
fect on SOCC activation [27, 28], but our current study, as
well as others, have indicated that STIM2 also acts as a
Ca2+ sensor [21, 23, 29, 30]. Here, we also demonstrated
that STIM2 is a significant player of SOCE in spinal astro-
cytes, though it is not as strong as STIM1. Similar to other
cell types [31, 32], Orai2 and Orai3 are not responsible for
the SOCE in spinal astrocytes. Knockdown of Orai1, how-
ever, reduced SOCE by 80 %, suggesting that Orai1 might
be the only STIM1-activated channel involved in TG-
induced SOCE. Thus, we revealed for the first time that
STIM1, STIM2, and Orai1 are the molecular components
responsible for SOCE in spinal astrocytes.
It is well documented that a decrease in ER Ca2+ re-
sults in a profound intracellular redistribution of STIM1
from a uniform ER pattern to spatially discrete areas
termed as puncta. This leads to the activation of the
Orai1 channel at the plasma membrane, allowing Ca2+
entry from the extracellular milieu [33–35]. In this study,
we also examined STIM1 redistribution and puncta for-
mation with Orai1. Our live-cell confocal images clearly
showed that reduction of ER Ca2+ by TG or CPA-induced
robust STIM1 puncta formation. Interestingly, we also
observed that TG and CPA induced Orai1 puncta-like
formation. Under the resting state, STIM1 formed a few
puncta with Orai1. After TG and CPA treatments, STIM1
formed substantial puncta that co-localized with Orai1.
Our result is consistent with the previous findings that
Orai1 and STIM1 move in a coordinated fashion to form
clusters in plasma membrane [36].
Pro-inflammatory cytokine production is one of the
biological markers of astrocyte activation. Numerous
studies reported that pro-inflammatory cytokines like
TNF-α and IL-6 are involved in pain hypersensitivity
[37, 38]. They are up-regulated in pain conditions [39, 40],
and intrathecal injection of these pro-inflammatory cyto-
kines can directly induce pain responses [41, 42]. Unlike
the well-known critical role of SOCCs in cytokine produc-
tion in immune cells [10], the role of SOCCs in cytokine
production in astrocytes has not been elucidated. In the
present study, we discovered that activation of SOCCs by
TG or CPA could induce TNF-α and IL-6 production in
spinal astrocytes. Both Gd3+ and YM-58483 significantly
decreased the TNF-α and IL-6 production induced by TG.
More importantly, we found that knockdown of STIM1
and Orai1 decreased TNF-α and IL-6 production in spinal
astrocytes. Consistent with previous studies, we observed
that TG reduced cell viability. However, this reduction was
not mediated by SOCE since inhibition of SOCE or knock-
down of STIM1 and Orai1 did not affect TG-induced
reduction of cell viability.
Since inhibition of Ca2+-ATPase is not a physiological
or pathological approach, we stimulated astrocytes using
LPS, a well-defined toll-like receptor (TLR) 2/4 agonist.
TLR2/4 receptors are implicated in several pathological
conditions such as rheumatoid arthritis [43, 44]. LPS in-
duced a large amount of TNF-α and IL-6 production
which was blocked by SOC inhibitors and knockdown of
STIM2 and Orai1 but not by knockdown of STIM1.
These findings suggest that STIM2 and Orai1 contribute
to LPS-induced cytokine production. LPS has been
shown to induce Ca2+ release from Ca2+ stores and elicit
Ca2+ oscillations in murine macrophages [45, 46]. Previ-
ous studies have demonstrated that STIM2 can activate
Ca2+ oscillations upon smaller decreases in ER Ca2+ by
low-level agonist concentrations [30, 47]. We used a very
low concentration (2 ng/ml) of LPS, which may only ac-
tivate STIM2. This might explain why a decrease in
STIM2 can reduce LPS-induced cytokine production.
Another possibility is that STIM2 constitutively interacts
with Orai1 to regulate basal Ca2+ concentration, which
enhances transcriptional activity [48, 49]. However, the
exact role of STIM2 and Orai1 in LPS-induced produc-
tion of pro-inflammatory cytokines and the cross-talk
between the STIM2/Orai1 and TLR signaling remain to
be explored.
Conclusions
We demonstrated that SOCCs are expressed in spinal
astrocytes, and we identified STIM1, STIM2, and Orai1
as the components responsible for SOCE. Our data also
demonstrated that SOCE can induce cytokine produc-
tion and that STIM2 and Orai1 play an important role
in LPS-induced cytokine production in spinal astrocytes.
These findings reveal a new calcium signal in spinal as-
trocytes and may suggest a possible therapeutic target
for treatment of chronic pain and other CNS disorders
associated with abnormal astrocyte activities.
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